Utility of serum ratio of heart-type fatty acid-binding protein to myoglobin for cardiac damage regardless of renal dysfunction

Circulation Journal

Volumn 68, Issue 7, 2004, Pages 656-659

  Furuhashi, Masato ^a   Ura, Nobuyuki ^a   Hasegawa, Koichi ^a   Tsuchihashi, Kazufumi ^a   Nakata, Tomoaki ^a   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

End stage renal disease; Heart type fatty acid binding protein; Hemodialysis; Myoglobin; Natriuretic peptide

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; FATTY ACID BINDING PROTEIN; HEART TYPE FATTY ACID BINDING PROTEIN; MYOGLOBIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEART INJURY; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE MASS; HEART VENTRICLE OVERLOAD; HEMODIALYSIS; HUMAN; KIDNEY DYSFUNCTION; MALE; PROTEIN BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; CARRIER PROTEINS; FATTY ACID-BINDING PROTEINS; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; MYOGLOBIN; REFERENCE VALUES; RENAL DIALYSIS;

EID: 3142624606     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.656     Document Type: Article

References (17)

1. Tanaka T, Hirota Y, Sohmiya K, Nishimura S, Kawamura K. Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clin Biochem 1991; 24: 195-201.
2. Seino Y, Tomita Y, Takano T, Ohbayashi K. Tokyo Rapid-test Office Cardiologists (Tokyo-ROC) Study. Office cardiologists cooperative study on whole blood rapid panel tests in patients with suspicious acute myocardial infarction: Comparison between heart-type fatty acid-binding protein and troponin T tests. Circ J 2004; 68: 144-148.
3. Setsuta K, Seino Y, Ogawa T, Arao M, Miyatake Y, Takano T. Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure. Am J Med 2002; 113: 717-722.
4. Wodzig KW, Kragten JA, Hermens WT, Glatz JF, van Dieijen-Visser MP. Estimation of myocardial infarct size from plasma myoglobin or fatty acid-binding protein. Influence of renal function. Eur J Clin Chem Clin Biochem 1997; 35: 191-198.
5. Gorski J, Hermens WT, Borawski J, Mysliwiec M, Glatz JF. Increased fatty acid-binding protein concentration in plasma of patients with chronic renal failure. Clin Chem 1997; 43: 193-195.
6. Yoshimoto K, Tanaka T, Somiya K, Tsuji R, Okamoto F, Kawamura K, et al. Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction. Heart Vessels 1995; 10: 304-309.
7. Van Nieuwenhoven FA, Kleine AH, Wodzig WH, Hermens WT, Kragten HA, Maessen JG, et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995; 92: 2848-2854.
8. Furuhashi M, Ura N, Hasegawa K, Yoshida H, Tsuchihashi K, Nakata T, et al. Serum ratio of heart-type fatty acid-binding protein to myoglobin: A novel marker of cardiac damage and volume overload in hemodialysis patients. Nephron Clin Pract 2003; 93: c69-c74.
9. Ohkaru Y, Asayama K, Ishii H, Nishimura S, Sunahara N, Tanaka T, et al. Development of a sandwich enzyme-linked immunosorbent assay for the determination of human heart type fatty acid-binding protein in plasma and urine by using two different monoclonal antibodies specific for human heart fatty acid-binding protein. J Immunol Methods 1995; 178: 99-111.
10. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
11. Sylven C, Jansson E, Book K. Myoglobin content in human skeletal muscle and myocardium: Relation to fibre size and oxidative capacity. Cardiovasc Res 1984; 18: 443-446.
12. Leunissen KM, Menheere PP, Cheriex EC, van den Berg BW, Noordzij TC, van Hooff JP. Plasma alpha-human atrial natriuretic peptide and volume status in chronic haemodialysis patients. Nephrol Dial Transplant 1989; 4: 382-386.
13. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995; 5: 2024-2031.
14. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001; 12: 1508-1515.
15. Kojima S, Inoue I, Hirata Y, Kimura G, Saito F, Kawano Y, et al. Plasma concentrations of immunoreactive-atrial natriuretic polypeptide in patients on hemodialysis. Nephron 1987; 46: 45-48.
16. Mair J, Artner-Dworzak E, Lechleitner P, Morass B, Smidt J, Wagner I, et al. Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin. Br Heart J 1992; 68: 462-468.
17. Katus HA, Remppis A, Neumann FJ, Scheffold T, Diederich KW, Vinar G, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83: 902-912.